|
CT383
|
U-CyTech Biosciences
|
U-CyTech TMB substrate solution; ELISA
|
|
ELISA
|
|
|
MD-05-0160
|
RayBiotech, Inc.
|
Mouse anti-Gram Positive Bacteria
|
Bacterial, Gram Positive spp.
|
Suitable for use in ELISA, IFA and colloidal gold conjugate.
|
|
|
MD-05-0463
|
RayBiotech, Inc.
|
Goat anti-Streptococcus Group A
|
Bacterial, Streptococcus spp.
|
Functions both as a capture and detection antibody in ELISA. Conjugates well with colloidal gold.
|
|
|
HY-13058B-10mg
|
MedChemexpress LLC
|
(R)-ADX-47273 [CAS 851881-59-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058B-5mg
|
MedChemexpress LLC
|
(R)-ADX-47273 [CAS 851881-59-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058B-50mg
|
MedChemexpress LLC
|
(R)-ADX-47273 [CAS 851881-59-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058B-1mL
|
MedChemexpress LLC
|
(R)-ADX-47273 [CAS 851881-59-9] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058-10mg
|
MedChemexpress LLC
|
ADX-47273 [CAS 851881-60-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058-100mg
|
MedChemexpress LLC
|
ADX-47273 [CAS 851881-60-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058-5mg
|
MedChemexpress LLC
|
ADX-47273 [CAS 851881-60-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058-50mg
|
MedChemexpress LLC
|
ADX-47273 [CAS 851881-60-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13058-1mL
|
MedChemexpress LLC
|
ADX-47273 [CAS 851881-60-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18654-10mg
|
MedChemexpress LLC
|
ADX88178 [CAS 1235318-89-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18654-5mg
|
MedChemexpress LLC
|
ADX88178 [CAS 1235318-89-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18654-50mg
|
MedChemexpress LLC
|
ADX88178 [CAS 1235318-89-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18654-1mL
|
MedChemexpress LLC
|
ADX88178 [CAS 1235318-89-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12177-10mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-12177-100mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-12177-5mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-12177-50mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-12177-1mL
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-133020-10mg
|
MedChemexpress LLC
|
ARD-266 [CAS 2666951-70-6]
|
|
Cancer-programmed cell death
|
|
|
HY-133020-5mg
|
MedChemexpress LLC
|
ARD-266 [CAS 2666951-70-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111052-10mg
|
MedChemexpress LLC
|
AZD7325 [CAS 942437-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-111052-100mg
|
MedChemexpress LLC
|
AZD7325 [CAS 942437-37-8]
|
|
COVID-19-immunoregulation
|
|
